Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons M. Djordjevic

Speerpunten

Mijn onderzoek is gericht op psychosociale factoren in de vroege stadia van psychosespectrumstoornissen.

Publicaties

Antipsychotic plasma concentration as predictor of movement disorders and cardiometabolic side-effects:: A comparison with prescription dose

Correction: Psychiatrists effect on positive symptom severity and daily functioning during pharmacotherapy for first-episode psychosis patients

Early Dose Reduction or Discontinuation vs Maintenance Antipsychotics After First Psychotic Episode Remission: A Randomized Clinical Trial

Social Currents, Inner Tides: A Scientific Investigation of Psychosocial Factors in Early-phase Psychotic Disorders

Association between the exposome score for schizophrenia and functioning in remitted first-episode psychosis: results from the HAMLETT study

Associations between momentary mental states and concurrent social functioning after remission from first episode psychosis: A HAMLETT ecological momentary assessment study

Psychological side effects of antipsychotic medication after remission from first-episode psychosis: a HAMLETT ecological momentary assessment study

Risk of relapse during tapering of antipsychotic medication after a first psychotic episode: association with D2 receptor affinity but not with tapering speed

The Effects of Antipsychotic Dose Reduction on Movement Disorders and Cardiometabolic Indices in Patients Remitted from a First Episode of Psychosis

Addressing the Evidence to Practice Gap: What to Expect from International Antipsychotic Dose Reduction Studies in the Tapering Anti-Psychotics and Evaluating Recovery Consortium

Sustainable Development Goals

SDG 3 – Goede gezondheid en welzijnSDG 16 – Vrede, rechtvaardigheid en sterke instellingen

Meer informatie over de Sustainable Development Goals.